INOGEN INC (INGN) Stock Fundamental Analysis

NASDAQ:INGN • US45780L1044

6.1 USD
-0.34 (-5.28%)
At close: Feb 27, 2026
6.1 USD
0 (0%)
After Hours: 2/27/2026, 5:20:02 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to INGN. INGN was compared to 185 industry peers in the Health Care Equipment & Supplies industry. The financial health of INGN is average, but there are quite some concerns on its profitability. INGN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year INGN has reported negative net income.
  • In the past year INGN has reported a negative cash flow from operations.
  • INGN had negative earnings in each of the past 5 years.
  • In multiple years INGN reported negative operating cash flow during the last 5 years.
INGN Yearly Net Income VS EBIT VS OCF VS FCFINGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -8.27%, INGN is in the better half of the industry, outperforming 64.32% of the companies in the same industry.
  • With a decent Return On Equity value of -12.87%, INGN is doing good in the industry, outperforming 65.95% of the companies in the same industry.
Industry RankSector Rank
ROA -8.27%
ROE -12.87%
ROIC N/A
ROA(3y)-21.41%
ROA(5y)-13.35%
ROE(3y)-32.95%
ROE(5y)-20.44%
ROIC(3y)N/A
ROIC(5y)N/A
INGN Yearly ROA, ROE, ROICINGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • With a Gross Margin value of 44.76%, INGN is not doing good in the industry: 62.70% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of INGN has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for INGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-0.6%
INGN Yearly Profit, Operating, Gross MarginsINGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

6

2. Health

2.1 Basic Checks

  • INGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • INGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INGN Yearly Shares OutstandingINGN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
INGN Yearly Total Debt VS Total AssetsINGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • INGN has an Altman-Z score of 1.54. This is a bad value and indicates that INGN is not financially healthy and even has some risk of bankruptcy.
  • INGN has a Altman-Z score (1.54) which is in line with its industry peers.
  • There is no outstanding debt for INGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.54
ROIC/WACCN/A
WACC9.93%
INGN Yearly LT Debt VS Equity VS FCFINGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • INGN has a Current Ratio of 3.14. This indicates that INGN is financially healthy and has no problem in meeting its short term obligations.
  • INGN has a Current ratio (3.14) which is comparable to the rest of the industry.
  • INGN has a Quick Ratio of 2.75. This indicates that INGN is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of INGN (2.75) is better than 62.70% of its industry peers.
Industry RankSector Rank
Current Ratio 3.14
Quick Ratio 2.75
INGN Yearly Current Assets VS Current LiabilitesINGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 48.03% over the past year.
EPS 1Y (TTM)48.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.59%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.05%

3.2 Future

  • Based on estimates for the next years, INGN will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.23% on average per year.
  • Based on estimates for the next years, INGN will show a small growth in Revenue. The Revenue will grow by 6.61% on average per year.
EPS Next Y11.56%
EPS Next 2Y9.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.43%
Revenue Next 2Y6.61%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

INGN Yearly Revenue VS EstimatesINGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
INGN Yearly EPS VS EstimatesINGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2 -3

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for INGN. In the last year negative earnings were reported.
  • Also next year INGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INGN Price Earnings VS Forward Price EarningsINGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INGN Per share dataINGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.23%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • INGN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

INOGEN INC

NASDAQ:INGN (2/27/2026, 5:20:02 PM)

After market: 6.1 0 (0%)

6.1

-0.34 (-5.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners72.63%
Inst Owner Change4.4%
Ins Owners2.18%
Ins Owner Change1.51%
Market Cap165.62M
Revenue(TTM)N/A
Net Income(TTM)-25.38M
Analysts82.5
Price Target13.26 (117.38%)
Short Float %3.43%
Short Ratio4.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)43.46%
Min EPS beat(2)42.07%
Max EPS beat(2)44.85%
EPS beat(4)4
Avg EPS beat(4)42.91%
Min EPS beat(4)33.97%
Max EPS beat(4)50.73%
EPS beat(8)7
Avg EPS beat(8)27.49%
EPS beat(12)9
Avg EPS beat(12)24.7%
EPS beat(16)11
Avg EPS beat(16)18.95%
Revenue beat(2)0
Avg Revenue beat(2)-0.95%
Min Revenue beat(2)-1.76%
Max Revenue beat(2)-0.15%
Revenue beat(4)2
Avg Revenue beat(4)1.43%
Min Revenue beat(4)-1.76%
Max Revenue beat(4)6.23%
Revenue beat(8)5
Avg Revenue beat(8)1.9%
Revenue beat(12)5
Avg Revenue beat(12)-0.4%
Revenue beat(16)8
Avg Revenue beat(16)0.2%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.62%
EPS NY rev (1m)0%
EPS NY rev (3m)1.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS12.78
BVpS7.26
TBVpS5.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.27%
ROE -12.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.76%
FCFM N/A
ROA(3y)-21.41%
ROA(5y)-13.35%
ROE(3y)-32.95%
ROE(5y)-20.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-0.6%
F-Score6
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 53.85%
Cap/Sales 3.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.14
Quick Ratio 2.75
Altman-Z 1.54
F-Score6
WACC9.93%
ROIC/WACCN/A
Cap/Depr(3y)106.82%
Cap/Depr(5y)105.29%
Cap/Sales(3y)6.42%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.59%
EPS Next Y11.56%
EPS Next 2Y9.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.05%
Revenue Next Year9.43%
Revenue Next 2Y6.61%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.48%
EBIT Next 3Y30.49%
EBIT Next 5YN/A
FCF growth 1Y43.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.64%
OCF growth 3Y-36.98%
OCF growth 5Y-31.97%

INOGEN INC / INGN FAQ

What is the fundamental rating for INGN stock?

ChartMill assigns a fundamental rating of 3 / 10 to INGN.


What is the valuation status for INGN stock?

ChartMill assigns a valuation rating of 0 / 10 to INOGEN INC (INGN). This can be considered as Overvalued.


How profitable is INOGEN INC (INGN) stock?

INOGEN INC (INGN) has a profitability rating of 2 / 10.


How financially healthy is INOGEN INC?

The financial health rating of INOGEN INC (INGN) is 6 / 10.